GLP-1 Pills and the Ongoing Importance of Nutrition Support
As oral GLP-1 therapies expand, thoughtful nutrition support remains essential for safe, sustainable outcomes.
A Role for GLP-1 in Treating Hyperphagia and Obesity
For patients exhibiting clinically clear signs of hyperphagia — such as chronic hunger, frequent snacking, and heightened food-cue reactivity — GLP-1 medications may offer significant relief. However, in addition to pharmacotherapy, a comprehensive treatment approach may be beneficial for these patients.
What Do We Know About the Long-Term Use of GLP-1 Medications?
Though GLP-1s are generally considered to be safe, we are still learning about the safety of the long-term use of GLP-1 medications.
The Cancer Risk Reduction Potential of Weight Loss: What Health Care Providers Need to Know
There is growing evidence that suggests intentional weight loss mediated by lifestyle change or pharmacotherapies can reduce cancer risk in adults.
Can a GLP-1 Medication Help Treat Binge Eating?
The use of GLP-1 for a binge eating disorder is evolving as a potentially transformative adjunctive approach for treatment.
Exploring the Cardiovascular Benefits of GLP-1 RAs in Patient Care
GLP-1 Cardiovascular Outcome Trials (CVOT)
Beyond Pharmaceuticals: Harnessing the Power of Meal Replacements in Your Weight Loss Practice
“After years of Yo-Yo dieting, using weight loss medication was a game-changer for me. But for true success and better health, I found that combining the medications with meal replacements and other lifestyle changes made all the difference.” — Quote…
Comparing Semaglutide, Tirzepatide, and Dulaglutide: How do They Stack Up?
Semaglutide, tirzepatide, and dulaglutide achieve similar results and have similar mechanisms of action, so the choice often comes down to preference and tolerability. Glucagon-like peptide-1 receptor agonists (GLP-1) medications are used to treat patients with type 2 diabetes and obesity…
How Semaglutide Effects Blood Sugar
Semaglutide lowers blood sugar and helps HbA1c levels drop to preferred ranges for patients with type 2 diabetes. Semaglutide, a synthetic form of the glucagon-like peptide 1 (GLP-1) hormone, is implicated in the regulation of blood glucose. Semaglutide increases…
How Does Stopping Semaglutide Affect Patients?
When patients stop taking semaglutide, health care providers should prepare them for possible withdrawal symptoms such as weight regain, increased appetite and food cravings, and the re-emergence of cardiovascular and metabolic risk factors. Semaglutide is an effective pharmacotherapy for helping…